Insmed (INSM) PT Raised to $144 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Maxwell Skor raised the price target on Insmed (NASDAQ: INSM) to $144.00 (from $126.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
